These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32197584)

  • 21. B and T lymphocyte attenuator regulates CD8+ T cell-intrinsic homeostasis and memory cell generation.
    Krieg C; Boyman O; Fu YX; Kaye J
    Nat Immunol; 2007 Feb; 8(2):162-71. PubMed ID: 17206146
    [TBL] [Abstract][Full Text] [Related]  

  • 22. B and T lymphocyte attenuator regulates B cell receptor signaling by targeting Syk and BLNK.
    Vendel AC; Calemine-Fenaux J; Izrael-Tomasevic A; Chauhan V; Arnott D; Eaton DL
    J Immunol; 2009 Feb; 182(3):1509-17. PubMed ID: 19155498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B and T lymphocyte attenuator mediates inhibition of tumor-reactive CD8+ T cells in patients after allogeneic stem cell transplantation.
    Hobo W; Norde WJ; Schaap N; Fredrix H; Maas F; Schellens K; Falkenburg JH; Korman AJ; Olive D; van der Voort R; Dolstra H
    J Immunol; 2012 Jul; 189(1):39-49. PubMed ID: 22634623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity.
    del Rio ML; Kurtz J; Perez-Martinez C; Ghosh A; Perez-Simon JA; Rodriguez-Barbosa JI
    Transplantation; 2011 Nov; 92(10):1085-93. PubMed ID: 21978997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CpG-ODN-induced sustained expression of BTLA mediating selective inhibition of human B cells.
    Thibult ML; Rivals JP; Mamessier E; Gertner-Dardenne J; Pastor S; Speiser DE; Derré L; Olive D
    J Mol Med (Berl); 2013 Feb; 91(2):195-205. PubMed ID: 22903545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Expression of the costimulatory molecule BTLA in synovial tissues from rheumatoid arthritis patients].
    Shang YJ; Cui QF; Li JL; Guo GN; Zhu WY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):643-6. PubMed ID: 22691359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation-induced accumulation of B and T lymphocyte attenuator at the immunological synapse in CD4+ T cells.
    Owada T; Watanabe N; Oki M; Oya Y; Saito Y; Saito T; Iwamoto I; Murphy TL; Murphy KM; Nakajima H
    J Leukoc Biol; 2010 Mar; 87(3):425-32. PubMed ID: 19892849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roles of BTLA in Immunity and Immune Disorders.
    Ning Z; Liu K; Xiong H
    Front Immunol; 2021; 12():654960. PubMed ID: 33859648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo CD86 blockade inhibits CD4+ T cell activation, whereas CD80 blockade potentiates CD8+ T cell activation and CTL effector function.
    Lang TJ; Nguyen P; Peach R; Gause WC; Via CS
    J Immunol; 2002 Apr; 168(8):3786-92. PubMed ID: 11937530
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of cyclosporin A on lymphocyte attenuator expression.
    Zeng C; Zhen Y; Shu SA; Wu T; Yi H; Lian ZX; Zhao Y
    J Autoimmun; 2007 Jun; 28(4):234-44. PubMed ID: 17449225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective roles of B and T lymphocyte attenuator in NKT cell-mediated experimental hepatitis.
    Iwata A; Watanabe N; Oya Y; Owada T; Ikeda K; Suto A; Kagami S; Hirose K; Kanari H; Kawashima S; Nakayama T; Taniguchi M; Iwamoto I; Nakajima H
    J Immunol; 2010 Jan; 184(1):127-33. PubMed ID: 19949073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells.
    Otsuki N; Kamimura Y; Hashiguchi M; Azuma M
    Biochem Biophys Res Commun; 2006 Jun; 344(4):1121-7. PubMed ID: 16643847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced non-switched memory B cell subsets cause imbalance in B cell repertoire in systemic sclerosis.
    Simon D; Balogh P; Bognár A; Kellermayer Z; Engelmann P; Németh P; Farkas N; Minier T; Lóránd V; Czirják L; Berki T
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):30-36. PubMed ID: 27056741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allergen-specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co-inhibitory molecule, in allergic rhinitis.
    Okano M; Otsuki N; Azuma M; Fujiwara T; Kariya S; Sugata Y; Higaki T; Kino K; Tanimoto Y; Okubo K; Nishizaki K
    Clin Exp Allergy; 2008 Dec; 38(12):1891-900. PubMed ID: 19016801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection.
    Han P; Goularte OD; Rufner K; Wilkinson B; Kaye J
    J Immunol; 2004 May; 172(10):5931-9. PubMed ID: 15128774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [THE IDENTIFICATION OF SUB-POPULATIONS OF B-LYMPHOCYTES OF PERIPHERAL BLOOD USING TECHNIQUE OF FLOW CYTOFLUOROMETRY IN HEALTHY INDIVIDUALS AND PATIENTS WITH RHEUMATOID DISEASES].
    Suponitskaia EV; Aleksankin AP; Aleksandrova EN; Avdeeva AS; Panafidina TA; Verijnikova JG; Nasonov EL
    Klin Lab Diagn; 2015 Jun; 60(6):30-3. PubMed ID: 26466448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [BTLA Characterization and its association with disease progression in patients with chronic HIV-1 infection.].
    Xu XS; Zhang Z; Gu LL; Wang FS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Dec; 25(12):1158-60. PubMed ID: 19961807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligation of B and T lymphocyte attenuator prevents the genesis of experimental cerebral malaria.
    Lepenies B; Pfeffer K; Hurchla MA; Murphy TL; Murphy KM; Oetzel J; Fleischer B; Jacobs T
    J Immunol; 2007 Sep; 179(6):4093-100. PubMed ID: 17785848
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of B and T lymphocyte attenuator, retinoid-related orphan receptor gamma-isoform-t and interleukin 7 in psoriasis vulgaris.
    Youssef RM; El-Ramly AZ; Hussien MF; Shoukry NM; Amr K
    Australas J Dermatol; 2019 May; 60(2):e132-e137. PubMed ID: 30671936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BTLA: a new inhibitory receptor with a B7-like ligand.
    Carreno BM; Collins M
    Trends Immunol; 2003 Oct; 24(10):524-7. PubMed ID: 14552835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.